Position in VCEL
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$6,270,415
-$1,046,708 QoQ
Shares Held
194,915
-4.1% QoQ
Ownership
0.382%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 36.94020470461483.ToString("F0")%
Shared 0.ToString("F0")%
None 63.05979529538517.ToString("F0")%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PEREGRINE CAPITAL MANAGEMENT LLC holds $94,824,642 across 14 Biotechnology names. VCEL ranks #10 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XENE |
Xenon Pharmaceuticals Inc.
|
143,136 | $8,323,358 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
146,923 | $8,299,680 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
47,296 | $7,993,969 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
201,959 | $7,773,401 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
306,272 | $7,215,768 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
146,606 | $7,207,150 | |
| 7 | CYTK |
Cytokinetics Inc
|
103,626 | $6,829,989 | |
| 8 | EWTX |
Edgewise Therapeutics, Inc.
|
208,672 | $6,573,168 |
All Filings in VCEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,270,415 | 194,915 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $7,317,123 | 203,197 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $6,480,554 | 205,928 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $8,993,070 | 211,353 | Shares | Sole | 2025-08-01 | |
| No filing history on record for this holder in this stock. | ||||||